{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:01:13Z","timestamp":1792188073906,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The impact of intrauterine exposure to maternal opioid use disorder (OUD) and opioid maintenance treatment (OMT) on child development is not fully understood. This population-based cohort study investigated the neurodevelopmental and behavioral outcomes of four-year-old children prenatally exposed to maternal OMT, hypothesizing greater challenges compared to their same-aged peers in Finland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Children with intrauterine exposure to buprenorphine\u00b1naloxone or methadone (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009123) were compared with typically developing children (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009434) using standardized language, motor-perceptual, and attention-behavioral skills screening tests. ICD-10 diagnoses for developmental and behavioral disorders were compared with national data from 50,457 Finnish children. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to assess risks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Children with prenatal OMT exposure exhibited significantly higher rates of developmental challenges as indicated by screening tests and ICD-10 diagnoses, including speech and language disorders, ADHD, conduct, emotional, and social disorders (F80, F90-94), with\n                      <jats:italic>ORs<\/jats:italic>\n                      ranging from\n                      <jats:italic>8.97 to 210.21<\/jats:italic>\n                      . Additional risk factors included male sex (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\n                      <jats:italic>0.001<\/jats:italic>\n                      ), methadone (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.004<\/jats:italic>\n                      ), illicit drug exposure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.011<\/jats:italic>\n                      ), and domestic violence (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.032<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Children born to mothers with OUD and OMT face significantly elevated risks of developmental and behavioral challenges. Close monitoring, stable environment and early support for these children with multiple risk factors are crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>This population-based cohort study demonstrates that children with in-utero exposure to maternal OMT are at high risk of neurodevelopmental, emotional and behavioral difficulties at age four.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Our results particularly add new knowledge of specific domains (skills) in neurodevelopmental screening tests and ICD-10 diagnoses in these children.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Beyond OMT, multiple additional risk factors such as fetal exposures to illicit substances or other harmful substances and postnatal environmental instability further compound the likelihood of later-life impairments.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>These findings emphasize the critical need for comprehensive follow-up, stable environment, and early interventions for this vulnerable group.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04029-6","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T19:30:41Z","timestamp":1743103841000},"page":"1737-1745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neurodevelopmental challenges at age four following fetal exposure to maternal opioid maintenance treatment"],"prefix":"10.1038","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0373-9500","authenticated-orcid":false,"given":"Minna M.","family":"Kanervo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarimari J.","family":"Tupola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva M.","family":"Nikkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna K.","family":"Kahila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista M.","family":"Rantakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"4029_CR1","unstructured":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. World Health Organization (2014)."},{"key":"4029_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.earlhumdev.2007.01.013","volume":"84","author":"RW Hunt","year":"2008","unstructured":"Hunt, R. W., Tzioumi, D., Collins, E. & Jeffery, H. E. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum. Dev. 84, 29\u201335 (2008).","journal-title":"Early Hum. Dev."},{"key":"4029_CR3","first-page":"268","volume":"8","author":"HM Kim","year":"2021","unstructured":"Kim, H. M. et al. Preschool language development of children born to women with an opioid use disorder. Child Basel Switz. 8, 268 (2021).","journal-title":"Child Basel Switz."},{"key":"4029_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.acap.2019.11.005","volume":"20","author":"SJ Lee","year":"2020","unstructured":"Lee, S. J., Bora, S., Austin, N. C., Westerman, A. & Henderson, J. M. T. Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis. Acad. Pediatr. 20, 308\u2013318 (2020).","journal-title":"Acad. Pediatr."},{"key":"4029_CR5","doi-asserted-by":"publisher","first-page":"e197025","DOI":"10.1001\/jamanetworkopen.2019.7025","volume":"2","author":"SL Yeoh","year":"2019","unstructured":"Yeoh, S. L., Eastwood, J. & Wright, I. M. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw. Open 2, e197025 (2019).","journal-title":"JAMA Netw. Open"},{"key":"4029_CR6","first-page":"1331","volume":"113","author":"AK Aslaksen","year":"2024","unstructured":"Aslaksen, A. K. et al. Children had increased risks of impaired motor and visual-motor skills after prenatal exposure to opioid maintenance therapy. Acta Paediatr. Oslo Nor. 1992 113, 1331\u20131339 (2024).","journal-title":"Acta Paediatr. Oslo Nor. 1992"},{"key":"4029_CR7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0562","volume":"142","author":"MMA Fill","year":"2018","unstructured":"Fill, M. M. A. et al. Educational disabilities among children born with neonatal abstinence syndrome. Pediatrics 142, e20180562 (2018).","journal-title":"Pediatrics"},{"key":"4029_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pedn.2019.12.011","volume":"51","author":"JS Miller","year":"2020","unstructured":"Miller, J. S., Anderson, J. G., Erwin, P. C., Davis, S. K. & Lindley, L. C. The effects of neonatal abstinence syndrome on language delay from birth to 10 years. J. Pediatr. Nurs. 51, 67\u201374 (2020).","journal-title":"J. Pediatr. Nurs."},{"key":"4029_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/pop.2018.0016","volume":"22","author":"ES Hall","year":"2019","unstructured":"Hall, E. S., McAllister, J. M. & Wexelblatt, S. L. Developmental disorders and medical complications among infants with subclinical intrauterine opioid exposures. Popul Health Manag 22, 19\u201324 (2019).","journal-title":"Popul Health Manag"},{"key":"4029_CR10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2651","volume":"139","author":"JL Oei","year":"2017","unstructured":"Oei, J. L. et al. Neonatal abstinence syndrome and high school performance. Pediatrics 139, e20162651 (2017).","journal-title":"Pediatrics"},{"key":"4029_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/pr.2015.95","volume":"78","author":"E Nygaard","year":"2015","unstructured":"Nygaard, E., Moe, V., Slinning, K. & Walhovd, K. B. Longitudinal cognitive development of children born to mothers with opioid and polysubstance use. Pediatr. Res. 78, 330\u2013335 (2015).","journal-title":"Pediatr. Res."},{"key":"4029_CR12","first-page":"e544","volume":"65","author":"S Welton","year":"2019","unstructured":"Welton, S., Blakelock, B., Madden, S. & Kelly, L. Effects of opioid use in pregnancy on pediatric development and behaviour in children older than age 2: Systematic review. Can. Fam. Physician Med Fam. Can. 65, e544\u2013e551 (2019).","journal-title":"Can. Fam. Physician Med Fam. Can."},{"key":"4029_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.114289","volume":"276","author":"SD Leverett","year":"2025","unstructured":"Leverett, S. D. et al. Associations between parenting and cognitive and language abilities at 2 years of age depend on prenatal exposure to disadvantage. J. Pediatr. 276, e114289 (2025).","journal-title":"J. Pediatr."},{"key":"4029_CR14","first-page":"668","volume":"43","author":"A Ornoy","year":"2001","unstructured":"Ornoy, A., Segal, J., Bar-Hamburger, R. & Greenbaum, C. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev. Med Child Neurol. 43, 668\u2013675 (2001).","journal-title":"Dev. Med Child Neurol."},{"key":"4029_CR15","first-page":"544","volume":"102","author":"V Sundelin Wahlsten","year":"2013","unstructured":"Sundelin Wahlsten, V. & Sarman, I. Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediatr. Oslo Nor. 1992 102, 544\u2013549 (2013).","journal-title":"Acta Paediatr. Oslo Nor. 1992"},{"key":"4029_CR16","doi-asserted-by":"publisher","first-page":"e077664","DOI":"10.1136\/bmj-2023-077664","volume":"385","author":"J Kang","year":"2024","unstructured":"Kang, J. et al. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. BMJ 385, e077664 (2024).","journal-title":"BMJ"},{"key":"4029_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","volume":"185","author":"K Kaltenbach","year":"2018","unstructured":"Kaltenbach, K. et al. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. Drug Alcohol Depend. 185, 40\u201349 (2018).","journal-title":"Drug Alcohol Depend."},{"key":"4029_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2023.107176","volume":"97","author":"L Bierce","year":"2023","unstructured":"Bierce, L., Tabachnick, A. R., Eiden, R. D., Dozier, M. & Labella, M. H. A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use. Neurotoxicol. Teratol. 97, e107176 (2023).","journal-title":"Neurotoxicol. Teratol."},{"key":"4029_CR19","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/dmcn.14808","volume":"63","author":"TA Levine","year":"2021","unstructured":"Levine, T. A., Davie-Gray, A., Kim, H. M., Lee, S. J. & Woodward, L. J. Prenatal methadone exposure and child developmental outcomes in 2-year-old children. Dev. Med. Child Neurol. 63, 1114\u20131122 (2021).","journal-title":"Dev. Med. Child Neurol."},{"key":"4029_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/aogs.14497","volume":"102","author":"MM Kanervo","year":"2023","unstructured":"Kanervo, M. M., Tupola, S. J., Nikkola, E. M., Rantakari, K. M. & Kahila, H. K. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder. Acta Obstet. Gynecol. Scand. 102, 313\u2013322 (2023).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"4029_CR21","first-page":"1579","volume":"113","author":"M Kanervo","year":"2024","unstructured":"Kanervo, M. et al. Intrauterine exposure to maternal opioid maintenance treatment and associated risk factors may impair child growth. Acta Paediatr. Oslo Nor. 1992 113, 1579\u20131591 (2024).","journal-title":"Acta Paediatr. Oslo Nor. 1992"},{"key":"4029_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejogrb.2024.04.003","volume":"297","author":"M Kanervo","year":"2024","unstructured":"Kanervo, M., Tupola, S., Nikkola, E., Rantakari, K. & Kahila, H. Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes. Eur. J. Obstet. Gynecol. Reprod. Biol. 297, 106\u2013110 (2024).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"4029_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1469-8749.2004.tb00502.x","volume":"46","author":"R Valtonen","year":"2004","unstructured":"Valtonen, R., Ahonen, T., Lyytinen, P. & Lyytinen, H. Co-ocurrence of developmental delays in a screening study of 4-year-old Finnish children. Dev. Med. Child Neurol. 46, 436\u2013443 (2004).","journal-title":"Dev. Med. Child Neurol."},{"key":"4029_CR24","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan, L. P., Connaughton, J. F. J., Kron, R. E. & Emich, J. P. Neonatal abstinence syndrome: assessment and management. Addict. Dis. 2, 141\u2013158 (1975).","journal-title":"Addict. Dis."},{"key":"4029_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10802-020-00766-w","volume":"49","author":"J Jaekel","year":"2021","unstructured":"Jaekel, J. et al. Emotional and behavioral trajectories of 2 to 9 years old children born to opioid-dependent mothers. Res. Child Adolesc. Psychopathol. 49, 443\u2013457 (2021).","journal-title":"Res. Child Adolesc. Psychopathol."},{"key":"4029_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2020.100625","volume":"11","author":"AM Koponen","year":"2020","unstructured":"Koponen, A. M. et al. Prenatal substance exposure, adverse childhood experiences and diagnosed mental and behavioral disorders - A longitudinal register-based matched cohort study in Finland. SSM - Popul Health 11, e100625 (2020).","journal-title":"SSM - Popul Health"},{"key":"4029_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/09297049.2011.628309","volume":"18","author":"TB Irner","year":"2012","unstructured":"Irner, T. B. Substance exposure in utero and developmental consequences in adolescence: A systematic review. Child Neuropsychol. 18, 521\u2013549 (2012).","journal-title":"Child Neuropsychol."},{"key":"4029_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nicl.2017.12.033","volume":"18","author":"VJ Monnelly","year":"2018","unstructured":"Monnelly, V. J. et al. Prenatal methadone exposure is associated with altered neonatal brain development. NeuroImage Clin. 18, 9\u201314 (2018).","journal-title":"NeuroImage Clin."},{"key":"4029_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41390-020-01265-w","volume":"90","author":"SL Merhar","year":"2021","unstructured":"Merhar, S. L. et al. Prenatal opioid exposure is associated with smaller brain volumes in multiple regions. Pediatr. Res. 90, 397\u2013402 (2021).","journal-title":"Pediatr. Res."},{"key":"4029_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ajad.12483","volume":"26","author":"EM Wachman","year":"2017","unstructured":"Wachman, E. M. et al. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity. Am. J. Addict. 26, 42\u201349 (2017).","journal-title":"Am. J. Addict."},{"key":"4029_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.earlhumdev.2016.08.013","volume":"101","author":"C Konijnenberg","year":"2016","unstructured":"Konijnenberg, C., Sarfi, M. & Melinder, A. Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine. Early Hum. Dev. 101, 91\u201397 (2016).","journal-title":"Early Hum. Dev."},{"key":"4029_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1353\/hpu.2023.0011","volume":"34","author":"SR Beldick","year":"2023","unstructured":"Beldick, S. R., Rohde, J. F., Short, V. L., Abatemarco, D. & Goyal, N. K. Pediatric primary care diagnosis patterns among children with intrauterine opioid exposure. J. Health Care Poor Underserved 34, 161\u2013179 (2023).","journal-title":"J. Health Care Poor Underserved"},{"key":"4029_CR33","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.clinthera.2019.06.003","volume":"41","author":"EL Winstanley","year":"2019","unstructured":"Winstanley, E. L. & Stover, A. N. The impact of the opioid epidemic on children and adolescents. Clin. Ther. 41, 1655\u20131662 (2019).","journal-title":"Clin. Ther."},{"key":"4029_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuropsychologia.2018.04.011","volume":"114","author":"A Etchell","year":"2018","unstructured":"Etchell, A. et al. A systematic literature review of sex differences in childhood language and brain development. Neuropsychologia 114, 19\u201331 (2018).","journal-title":"Neuropsychologia"},{"key":"4029_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/jpepsy\/jsaa008","volume":"45","author":"M Skumlien","year":"2020","unstructured":"Skumlien, M., Ibsen, I. O., Kesmodel, U. S. & Nygaard, E. Sex differences in early cognitive development after prenatal exposure to opioids. J. Pediatr. Psychol. 45, 475\u2013485 (2020).","journal-title":"J. Pediatr. Psychol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04029-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:04:50Z","timestamp":1762880690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04029-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4029"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04029-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research followed the ethical requirements of the Helsinki University Hospital, Finland. In Finland, patient consent is not required for the use of aggregated statistical data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}